Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of Stock Options Activity

The following table summarizes stock option activity during the three months ended March 31, 2024, (in thousands, except per share data).

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Total Intrinsic Value
Outstanding as of January 1, 2024	2,951	$	7.30	4.8	$	693
Granted	1,790	6.00		7.0	—
Forfeited	(289)	8.81		—	—
Outstanding as of March 31, 2024	4,452	$	6.68	5.6	3,012
Options vested and exercisable	2,235	$	6.43	4.7	2,290

Schedule of Weighted Average Assumptions Used in Determining Fair Value of Options

The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during the three months ended March 31, 2024 and 2023:

	For the three months ended
	March 31, 2024			March 31, 2023
Exercise price	$	6.00		$	6.84
Expected term (years)	4.5			4.3
Expected stock price volatility	79.6		%	80.9		%
Risk-free rate of interest	4.2		%	3.8		%
Expected dividend yield (per share)	0		%	0		%

Schedule of Warrant Activity

The following table summarizes warrant activity during the three months ended March 31, 2024 (in thousands, except per share data):

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life  (in years)
Outstanding as of January 1, 2024	831	$	11.16	1.9
Forfeited	(455)	12.83
Outstanding as of March 31, 2024	376	$	9.13	3.9
Warrants vested and exercisable	376	$	9.13	3.9